Healthcare group McKesson and private equity firm Clayton Dubilier & Rice are closing in on a deal to buy Option Care Health, the largest independent provider of medical infusion services in the US, valuing the business at more than $5bn including debt.
A deal could be reached as soon as Tuesday, but discussions could still fall apart. Option Care served over 315,000 patients last year via at-home infusions and 184 care centres.
Under the terms being discussed, CD&R would own a 51% stake in Option Care through a joint venture with McKesson, which would own a 49% stake. McKesson would have the right to purchase CD&R's stake in the future.
Shares in Option Care jumped 22% in post-market trading on Monday after the FT reported the potential go-private deal.
Source: Financial Times Companies · Summarized by HeadlinesBriefing